Anti-Aging Protocol

Overview

Anti-aging peptide protocols target the cellular and molecular mechanisms of aging rather than addressing individual symptoms. The three primary axes of this approach are telomere maintenance (through telomerase activation), extracellular matrix remodeling and tissue rejuvenation (through copper peptide signaling), and mitochondrial function optimization (through mitochondrial-derived peptides).

This protocol combines three compounds that each address a distinct hallmark of aging:

• Epithalon — a synthetic tetrapeptide that activates telomerase, the enzyme responsible for maintaining telomere length
• GHK-Cu — a naturally occurring copper-binding tripeptide involved in tissue remodeling, wound healing, and gene expression regulation
• MOTS-c — a mitochondrial-derived peptide that regulates metabolic homeostasis and cellular energy production

The theoretical foundation is that simultaneously supporting telomere integrity, tissue quality, and mitochondrial function addresses aging across multiple levels — genomic, structural, and metabolic.

Compounds Involved

Epithalon (Epitalon)

Epithalon is a synthetic version of the naturally occurring polypeptide epithalamin, which is produced by the pineal gland. Research by Dr. Vladimir Khavinson demonstrated that Epithalon activates the catalytic subunit of telomerase (hTERT), the enzyme that adds TTAGGG repeats to the ends of chromosomes. Telomere shortening is one of the primary hallmarks of cellular aging — each cell division erodes telomere length, and critically short telomeres trigger cellular senescence or apoptosis.

Beyond telomerase activation, Epithalon has been studied for its effects on melatonin production, circadian rhythm regulation, and antioxidant enzyme expression.

GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Plasma levels of GHK-Cu decline significantly with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60.

Research has identified GHK-Cu as a broad gene expression modulator, affecting over 4,000 genes. Its effects include stimulation of collagen and elastin synthesis, promotion of glycosaminoglycan production, activation of wound healing and tissue remodeling, antioxidant enzyme upregulation, and anti-inflammatory signaling.

GHK-Cu can be administered both systemically (SubQ injection) and topically (creams, serums) — see Topical Application.

MOTS-c

MOTS-c (Mitochondrial Open Reading Frame of the Twelve S rRNA type-c) is a 16-amino-acid peptide encoded by mitochondrial DNA. It is classified as a mitochondrial-derived peptide (MDP) and functions as a metabolic regulator. MOTS-c activates AMPK (AMP-activated protein kinase), a master regulator of cellular energy metabolism, and has been shown to improve glucose metabolism, enhance exercise capacity, and protect against metabolic dysfunction in preclinical models.

MOTS-c levels decline with age, and supplementation is being studied as a strategy to restore youthful metabolic signaling.

Protocol Structure

Epithalon Cycles

Epithalon is administered in short, intensive cycles rather than continuously:

Standard Epithalon cycle:

• Dose: 5–10 mg per day
• Route: Subcutaneous injection, abdomen
• Duration: 10–20 consecutive days
• Frequency: 2–3 cycles per year, spaced 4–6 months apart
• Timing: No specific fasting requirement; evening administration is common due to melatonin-related effects

GHK-Cu Protocol

GHK-Cu can be used on an ongoing or cycling basis:

Systemic (injectable):

• Dose: 1–2 mg per day
• Route: Subcutaneous injection
• Duration: 8–12 weeks, followed by a 4-week break
• Timing: No specific fasting requirement

Topical:

• Application: GHK-Cu serum or cream applied to face, neck, and target areas
• Frequency: 1–2 times daily
• Duration: Can be used continuously; topical GHK-Cu does not carry the same cycling concerns as injectable

MOTS-c Protocol

Standard protocol:

• Dose: 5–10 mg per injection
• Route: Subcutaneous injection
• Frequency: 3–5 times per week
• Duration: 8–12 weeks, followed by a 4-week break
• Timing: Morning administration is common; some practitioners time it before exercise to leverage AMPK activation

Combined Protocol Calendar

A practical approach to running all three compounds:

This is an example framework. The key principle is that Epithalon is administered in concentrated bursts, while GHK-Cu and MOTS-c follow standard on/off cycling patterns.

Synergistic Additions

Several other compounds complement this protocol:

• Ipamorelin + Mod GRF 1-29: GH secretagogues support tissue repair and body composition. See GH Secretagogue Protocol.
• NAD+ precursors: NMN or NR supplementation supports mitochondrial function alongside MOTS-c.
• Melatonin: Low-dose melatonin (0.3–1 mg) complements Epithalon's pineal gland effects. See Sleep Optimization Protocol.
• Vitamin D3 + K2: Supports bone density and immune function, both of which decline with age.

Important Considerations

• Long-term perspective: Anti-aging protocols are inherently long-term endeavors. Single cycles of any compound are unlikely to produce dramatic results. Consistency over years is the operative framework.
• Biomarker tracking: Objective assessment of anti-aging protocols requires biomarker monitoring. Relevant markers include telomere length testing (available through specialized labs), fasting glucose and HbA1c, inflammatory markers (hsCRP, IL-6), IGF-1 levels, and skin elasticity measurements.
• Telomerase activation context: While Epithalon's telomerase activation is generally considered beneficial for healthy cells, any compound that promotes cellular proliferation warrants caution in individuals with active or recent malignancies. Consult an oncologist in such cases.
• GHK-Cu quality: Copper peptide quality varies significantly between suppliers. The copper complex must be properly formed — free copper without peptide binding is pro-oxidant rather than antioxidant. See Quality Assessment.
• MOTS-c and exercise: MOTS-c appears to have synergistic effects with exercise. Combining this protocol with regular physical activity (both resistance training and cardiovascular exercise) is strongly recommended.
• Cycling is essential: See Peptide Cycling for detailed guidance on managing receptor sensitivity and off periods.

Disclaimer

This article is for educational and informational purposes only. It does not constitute medical advice, and no therapeutic claims are made. Peptide research is ongoing, and individual outcomes may vary. Consult a qualified healthcare professional before beginning any peptide protocol. All compounds discussed are intended for research purposes.